Arcellx Inc., a private biotech developing tumor-fighting therapies, has raised $85 million. The company, which has been relatively quiet since its 2015 founding, announced Thursday the Series B raise to advance its cell therapy technology. The financing includes $41.8 million the company secured in August, according to Securities and Exchange Commission filings. And that followed a Series A in 2017 of an undisclosed amount. Two new international investors, Korea-based Aju IB Investment and China-based…
from https://www.bizjournals.com/baltimore/news/2019/10/07/gaithersburg-cancer-therapy-company-raises-85m.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/188196521877
No comments:
Post a Comment